Who is sponsoring NCT04037540?

NCT04037540 is sponsored by University Hospital Ostrava.

What drugs are being tested in NCT04037540?

Interventions in NCT04037540: Operational approach, Conservative approach.

What condition does NCT04037540 study?

NCT04037540 studies Fracture of Fifth Metatarsal Bone.

Is NCT04037540 still recruiting?

NCT04037540 is currently completed. Last updated 31 July 2019.

Last reviewed 2019-07-31 · How we verify

NCT04037540

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Conservative and Operative Treatment of Jones Fracture

Completed NA Last updated 31 July 2019

What this trial tests

NA trial testing Operational approach in Fracture of Fifth Metatarsal Bone in 27 participants. Completed in 31 December 2018.

Timeline

1 January 2006

Primary endpoint
31 December 2011

31 December 2018

Quick facts

Lead sponsor	University Hospital Ostrava
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	27
Start date	1 January 2006
Primary completion	31 December 2011
Estimated completion	31 December 2018
Sites	1 location across Czechia

Drugs / interventions tested

Operational approach
Conservative approach

Conditions studied

Fracture of Fifth Metatarsal Bone — all drugs for Fracture of Fifth Metatarsal Bone →

Sponsor

University Hospital Ostrava

Who can join

Adults 18 to 70, any sex, with Fracture of Fifth Metatarsal Bone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study deals with the topic of treatment of Jones fracture, comparing surgical and conservative approach. The fracture occurs especially in highly active individuals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Conservative and Operative Treatment of Jones Fracture
Demel J, Planka L, Stichhauer R, Pleva L. · · 2019 · DOI 10.21203/rs.2.14565/v1

Verify or expand the search:

Other University Hospital Ostrava trials

Trials by the same sponsor.

NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07041086 — Prehospital ECPR in Moravia Silesia Region · recruiting
NCT07009652 — Optimization of Transport and Use of a Mobile ECMO Team in Patients With Sudden Cardiac Arrest in the Moravian-Silesian · recruiting
NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04037540 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Ostrava
Last refreshed: 31 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04037540.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing